Your account is not claimed yet. You can sign up with ORCID to claim your account.

Xavier Tekpli

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 8

Top Venues

Oncoimmunology

Genome medicine

NAR cancer

Nature communications

Oslo University Hospital

University of Rennes (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oslo University Hospital Nov 1o 2015

Norway

Postdoctoral fellow :: Institutoe of Cancer Research, Department of Cancer Genetics

Education History

University of Rennes

France

PHD :: INSERM U620

Publications

Sunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen, Johan Vallon-Christersson, Surendra Kumar, Katrine Bull Evensen, Thomas Fleischer, Jorg Tost, null null, Kristine K Sahlberg, Anthony Mathelier, Gyan Bhanot, Shridar Ganesan, Xavier Tekpli, Vessela N Kristensen
Subtype and cell type specific expression of lncRNAs provide insight into breast cancer. Communications biology 5 (1) (2022)
Jørgen Ankill, Miriam Ragle Aure, Sunniva Bjørklund, Geir Severin R E Langberg, null null, Vessela N Kristensen, Valeria Vitelli, Xavier Tekpli, Thomas Fleischer
Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer. NAR cancer 4 (1) (2022)
Miriam Ragle Aure, Thomas Fleischer, Sunniva Bjørklund, Jørgen Ankill, Jaime A Castro-Mondragon, null null, Anne-Lise Børresen-Dale, Jorg Tost, Kristine K Sahlberg, Anthony Mathelier, Xavier Tekpli, Vessela N Kristensen
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer. Genome medicine 13 (1) (2021)
Mari Tinholt, Benedicte Stavik, Xavier Tekpli, Øystein Garred, Elin Borgen, Vessela Kristensen, Kristine Kleivi Sahlberg, Per Morten Sandset, Nina Iversen
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer. Oncoimmunology 9 (1) (2020)
Xavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, Daniel Nebdal, Elin Borgen, Hege Oma Ohnstad, Jon Amund Kyte, Johan Vallon-Christersson, Marie Fongaard, Eldri Undlien Due, Lisa Gregusson Svartdal, My Anh Tu Sveli, Øystein Garred, null null, Arnoldo Frigessi, Kristine Kleivi Sahlberg, Therese Sørlie, Hege G Russnes, Bjørn Naume, Vessela N Kristensen
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nature communications 10 (1) (2019)
Marianne E Nome, Leslie R Euceda, Shakila Jabeen, Julia Debik, Tone F Bathen, Guro F Giskeødegård, Kristin A Taskén, Gunhild M Maelandsmo, Bente Halvorsen, Arne Yndestad, Elin Borgen, Øystein Garred, Pål Aukrust, Thor Ueland, Olav Engebraaten, Vessela N Kristensen, Xavier Tekpli
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International journal of cancer 146 (1) (2019)
Shakila Jabeen, Jaime A Espinoza, Lilly Anne Torland, Manuela Zucknick, Surendra Kumar, Vilde D Haakensen, Torben Lüders, Olav Engebraaten, Anne-Lise Børresen-Dale, Jon Amund Kyte, Pavel Gromov, Bjørn Naume, Vessela N Kristensen, Irina Gromova, Xavier Tekpli
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics. Oncoimmunology 8 (2) (2018)
Xavier Tekpli, Vidar Skaug, Rita Bæra, David H Phillips, Aage Haugen, Steen Mollerup
Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report. Cellular oncology (Dordrecht) 39 (6) (2016)

Xavier Tekpli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xavier Tekpli